131 related articles for article (PubMed ID: 7606321)
21. [Desmopressin in the treatment of hemorrhagic diathesis].
Haar D; Hasselbalch HC
Ugeskr Laeger; 1995 Nov; 157(48):6713-5. PubMed ID: 8540136
[TBL] [Abstract][Full Text] [Related]
22. Ehlers-Danlos syndrome: historical review, report of two cases in one family and treatment needs.
Welbury RR
ASDC J Dent Child; 1989; 56(3):220-4. PubMed ID: 2656795
[TBL] [Abstract][Full Text] [Related]
23. Oral manifestations of Ehlers-Danlos syndrome.
Létourneau Y; Pérusse R; Buithieu H
J Can Dent Assoc; 2001 Jun; 67(6):330-4. PubMed ID: 11450296
[TBL] [Abstract][Full Text] [Related]
24. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
Michiels JJ; Gadisseur A; Budde U; Berneman Z; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
[TBL] [Abstract][Full Text] [Related]
25. [Abdominal emergencies in type IV ehlers-Danlos syndrome].
Benchellal ZA; Huten N; Danquechin Dorval E; Podeur L; Rahili A; Lemeret S; De Muret A
Gastroenterol Clin Biol; 1998 Mar; 22(3):343-5. PubMed ID: 9762220
[TBL] [Abstract][Full Text] [Related]
26. [Concomitant neuropsychiatric symptoms in a case of Ehlers-Danlos syndrome].
Fehlow P; Tennstedt A
Psychiatr Neurol Med Psychol (Leipz); 1985 Apr; 37(4):215-20. PubMed ID: 4001232
[TBL] [Abstract][Full Text] [Related]
27. A novel therapeutic strategy for Ehlers-Danlos syndrome based on nutritional supplements.
Mantle D; Wilkins RM; Preedy V
Med Hypotheses; 2005; 64(2):279-83. PubMed ID: 15607555
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects. A double-blind placebo-controlled trial.
Rao AK; Ghosh S; Sun L; Yang X; Disa J; Pickens P; Polansky M
Thromb Haemost; 1995 Oct; 74(4):1071-8. PubMed ID: 8560416
[TBL] [Abstract][Full Text] [Related]
29. [Skin alterations in Ehlers-Danlos syndrome].
Wollina U
Dtsch Med Wochenschr; 2002 Jan; 127(3):100-1. PubMed ID: 11797148
[No Abstract] [Full Text] [Related]
30. Pulmonary valvuloplasty in a case of vascular Ehlers-Danlos syndrome.
Tsai-Goodman B; Martin RP; Pope FM; Stuart AG
Catheter Cardiovasc Interv; 2002 Sep; 57(1):92-4. PubMed ID: 12203938
[TBL] [Abstract][Full Text] [Related]
31. Bleeding times and DDAVP.
Crosby E
Reg Anesth; 1996; 21(5):496-8. PubMed ID: 8896024
[No Abstract] [Full Text] [Related]
32. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
33. Early-onset periodontitis in a patient with Ehlers-Danlos syndrome type III.
Reichert S; Riemann D; Plaschka B; Machulla HK
Quintessence Int; 1999 Nov; 30(11):785-90. PubMed ID: 10765879
[TBL] [Abstract][Full Text] [Related]
34. Hemorrhagic shock resulting from post-coital vaginal bleeding in an adolescent with Ehlers-Danlos type IV.
Howard JM; Diaz MC; Soler ME
Pediatr Emerg Care; 2009 Jun; 25(6):397-8. PubMed ID: 19528762
[TBL] [Abstract][Full Text] [Related]
35. Abnormality of dermal collagen fibrils in Ehlers Danlos syndrome. Anticipation of the abnormality for the inherited hypermobile disorders.
Kobayasi T
Eur J Dermatol; 2004; 14(4):221-9. PubMed ID: 15319154
[TBL] [Abstract][Full Text] [Related]
36. The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977-2007).
Federici AB
Haemophilia; 2008 Jan; 14 Suppl 1():5-14. PubMed ID: 18173689
[TBL] [Abstract][Full Text] [Related]
37. [Disorders of blood coagulation in renal insufficiency: changes caused by desamino-8-D-arginine vasopressin].
Lens XM; Casals FJ; Oliva JA; Pascual R; Carrió J; Mallafré JM
Med Clin (Barc); 1988 Apr; 90(15):603-6. PubMed ID: 3260985
[No Abstract] [Full Text] [Related]
38. The clinical presentation of Ehlers-Danlos syndrome.
Lawrence EJ
Adv Neonatal Care; 2005 Dec; 5(6):301-14. PubMed ID: 16338669
[TBL] [Abstract][Full Text] [Related]
39. Treatment of von Willebrand's disease.
Mannucci PM
J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
[TBL] [Abstract][Full Text] [Related]
40. Cerebrovascular complications in Ehlers-Danlos syndrome type IV.
North KN; Whiteman DA; Pepin MG; Byers PH
Ann Neurol; 1995 Dec; 38(6):960-4. PubMed ID: 8526472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
